Healthcare -
Biotechnology - NASDAQ - US
$ 30.75
-0.646 %
$ 13.7 B
Market Cap
12.11
P/E
RPRX - RESEARCH & DEVELOPMENT
Research & Development RPRX - Royalty Pharma plc
52 M
LAST VALUE
-49.02%
2 YEAR CAGR
-33.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR